Fig. 1: Relative proportion of disease indications for HCT in 2022.
Green shades: myeloid malignancies, blue: lymphoid malignancies, brown: solid tumors and red: non malignant disorders. a Allogeneic 1st HCT. b Autologous 1st HCT.
Fig. 1: Relative proportion of disease indications for HCT in 2022. | Bone Marrow Transplantation
